Skip to main content

BMS 215 Pill - green five-sided

Generic Name: daclatasvir

Pill with imprint BMS 215 is Green, Five-sided and has been identified as Daklinza 60 mg. It is supplied by Bristol-Myers Squibb Company.

Daklinza is used in the treatment of Hepatitis C and belongs to the drug class NS5A inhibitors. Daklinza 60 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 215

Daklinza 60 mg BMS 215
Daklinza 60 mg BMS 215

Daklinza

Generic Name
daclatasvir
Imprint
BMS 215
Strength
60 mg
Color
Green
Shape
Five-sided
Availability
Prescription only
Drug Class
NS5A inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb Company
National Drug Code (NDC)
00003-0215 (Discontinued)
Inactive Ingredients
lactose anhydrous, microcrystalline cellulose, croscarmellose sodium, silicon dioxide, magnesium stearate, titanium dioxide, polyethylene glycol 400, FD&C Blue No. 2, indigotindisulfonate sodium, aluminum oxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.